(Q46791645)

25 December 2017

title

Time course and pattern of blood loss with ibuprofen treatment in healthy subjects (English)

1 reference

25 December 2017

author name string

Barry Bowen

1

1 reference

25 December 2017

Yuhong Yuan

2

1 reference

25 December 2017

Cindy James

3

1 reference

25 December 2017

Ferid Rashid

4

1 reference

25 December 2017

Richard H Hunt

5

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

25 December 2017

Clinical Gastroenterology and Hepatology

published in

1 reference

25 December 2017

volume

3

1 reference

25 December 2017

issue

11

1 reference

25 December 2017

page(s)

1075-1082

1 reference

25 December 2017

Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Outcome of endoscopic treatment for peptic ulcer bleeding: Is a second look necessary? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Visible small-intestinal mucosal injury in chronic NSAID users

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Iron deficiency anaemia in patients with rheumatic disease receiving non-steroidal anti-inflammatory drugs: the role of upper gastrointestinal lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Assessment of non-steroidal anti-inflammatory drug (NSAID) damage in the human gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Complementary studies of the gastrointestinal safety of the cyclo-oxygenase-2-selective inhibitor etoricoxib

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Radiochromium (chromium-51) evaluation of gastrointestinal blood loss associated with placebo, aspirin, and nabumetone

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Gastrointestinal Microbleeding Associated with the Use of Etodolac, Ibuprofen, Indomethacin, and Naproxen in Normal Males

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Nonselective nonaspirin nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding: relative and absolute risk estimates from recent epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin--analysis of gastrointestinal bleeding during the UK-TIA trial

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Toxicity of Nonsteroidal Anti-Inflammatory Drugs in the Elderly: Is Advanced Age a Risk Factor?

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Influence of age on the enantiomeric disposition of ibuprofen in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Risk factors for adverse events in analgesic drug users: results from the PAIN study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

An approximate Bayesian risk-analysis for the gastro-intestinal safety of ibuprofen.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Long term follow-up studies of users of nonprescription medicines purchased from community pharmacies: some methodological issues

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Effect of ibuprofen on cardioprotective effect of aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

Biliary excretion of radiochromium

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900605-1

7 January 2021

10.1016/S1542-3565(05)00605-1

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017